Lynn O'Connor Vos, CEO of Muscular Dystrophy Association, discusses its role as both traditional backer of research and now as aggregator of genetic and clinical data that can help uncover new treatments
Category: Crossing the Valley
For the past 17 years, Bruce Bloom, MD, CEO of Cures within Reach, has been proselytizing the virtues of drug repurposing while helping to advance treatments for more than a dozen diseases. Here's why drug repurposing can be a cheaper, faster and often safer way to bring more treatments to market.
Alan Koncarevic, Director of Industry Relations at Polsky, is creating the blueprint for how universities can work with industry and advance their common interests.